BCG vaccination strategy implemented to reduce the impact of COVID-19: Hype or Hope?

Rajarshi, Keshav; Chatterjee, Aroni; Ray, Shashikant

Rajarshi, Keshav; Chatterjee, Aroni; Ray, Shashikant.

Afiliação

Rajarshi K; School of Community Science and Technology (SOCSAT) Indian Institute of Engineering Scince and Technology (IIEST), Shibpur, Howrah, West Bengal 711103, India.
Chatterjee A; Indian Council of Medical Research (ICMR)-Virus Research Laboratory, NICED, Kolkata, India.
Ray S; Department of Biotechnology, Mahatma Gandhi Central University, Motihari 845401, India.

Med Drug Discov ; 7: 100049, 2020 Sep.

Article em En | MEDLINE | ID: mdl-32835211

Palavras-chave

BCG immunization; BCG, Bacille Calmette-Guérin; COVID-19; COVID-19, Coronavirus Disease 2019; ICAM-1, Intracellular adhesion molecule-1; IFN-Î³, Interferon gamma; IL-1ß, Interleukin-1ß; Immunity and Tuberculosis; LFA-1, Lymphocytes function associated antigens-1; MERS-CoV, Middle East Respiratory Syndrome coronavirus; NSEs, Non-specific effects; SARS-CoV-2; SARS-CoV-2S, Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein; TCR, T cell receptor; TNF-α, Tumor necrosis factor; WHO, World Health Organization

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Med Drug Discov Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google